Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines

Molecular Carcinogenesis

Volumn 28, Issue 2, 2000, Pages 102-110

  Wang, Weiqun ^a   Heideman, Laura ^a   Chung, Chilly S ^a   Pelling, Jill C ^b   Koehler, Kenneth J ^c   Birt, Diane F ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c Department of Statistics Center for Statistics and Applications in Forensic Evidence Iowa State University 2438 Osborn Dr Ames   (United States)

Author keywords

Apigenin; Cell culture; Cell cycle arrest; Colon carcinoma; Flavonoids

Indexed keywords

APIGENIN; FLAVONOID;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G2 PHASE; COLON CARCINOMA; CONTROLLED STUDY; DIET; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APIGENIN; CDC2 PROTEIN KINASE; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN B; FLAVONOIDS; G2 PHASE; HUMANS; MITOSIS; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0033933197     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-2     Document Type: Article

References (43)

1. Steinmetz KA, Potter JD. Vegetables, fruits and cancer. I. Epidemiology. Cancer Causes Control 1991;2:325-357.
2. Block G, Patterson B, Subar A. Fruits, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 1992;18:1-29.
3. Willett W. The search for the causes of breast and colon cancer. Nature 1989;338:389-394.
4. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 1992;52(suppl):2085S-2091S.
5. Boone CW, Kelloff GJ, Malane WF. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 1990;50:2-9.
6. Harborne JB. General procedures and measurement of total phenolics. In: Dey PM, Harborne JB, editors. Methods in plant biochemistry. London: Academic Press: 1989. p 1-28.
7. Lewis NG. Plant phenolics. In: Alscher RG, Hess JL, editors. Antioxidants in higher plants. Boca Raton CRC Press; 1993. p 135-169.
8. Birt DF, Shull JS, Yaktine AL. Chemoprevention of cancer. In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in health and disease. Baltimore: Williams & Wilkins; 1998. p 1263-1295.
9. Matern U, Heller W, Himmelspach K. Conformational changes of apigenin 7-O-(6-O-malonylglucoside), a vacuolar pigment from parsley, with solvent composition and protein concentration. Eur J Biochem 1983;133:439-448.
10. Fernandez-de-Simon B, Perez-Ilzarbe J, Hernandez T, Gomez-Cordoves C, Estrella I. Importance of phenolic compounds for the characterization of fruit juices. J Agric Food Chem 1992;40:1531-1535.
11. Engelhardt UH, Finger A, Kuhr S. Determination of flavones C-glycosides in tea. Z Lebensm Unters Forsch 1993;197: 239-244.
12. Peryt B, Szymczyk T, Lesca P. Mechanism of antimutagenicity of wheat sprout extracts. Mutat Res 1992;269:201-215.
13. Hirano T, Oka K, Akiba M. Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol 1989;64:69-78.
14. Lee SJ, Choi JH, Son KH, Chang HW, Kang SS, Kim HP. Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. Life Sci 1995;57:551-558.
15. Fotsis T, Pepper MS, Aktas E, et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997;57:2916-2921.
16. Kuo M, Lee K, Lin J. Genotoxicities of nitropyrenes and their modulation by apigenin, tannic acid, ellagic acid and indole-3-carbinol in the Salmonella and CHO systems. Mutat Res 1992;270:87-95.
17. Kuo ML, Yang NC. Reversion of v-H-RAS-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem. Biophys Res Commun 1995;212:767-775.
18. Wei H, Tye L, Bresnick E, Birt DF. Inhibitory effect of apigenin, a plant flavonoid, on ornithine decarboxylase and skin tumor promotion. Cancer Res 1990;50:499-502.
19. Chaumontet C, Bex V, Gaillard-Sanchez I, Seillan-Heberden C, Suschetet M, Martel P. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. Carcinogenesis 1994;15:2325-2330.
20. Panes J, Gerritsen ME, Anderson DC, Miyasaka M, Granger DN. Apigenin inhibits tumor necrosis factor-induced intercellular adhesion molecular-1 upregulation in vivo. Microcirculation 1996;3:279-286.
21. Birt DF, Mitchell D, Gold B, Pour P, Pinch H. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 1996;17: 85-92.
22. Lepley DM, Li B, Birt DF, Pelling JC. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 1996;17:2367-2375.
23. Lepley DM, Pelling JC. Induction of p21/WAF1 and G1 cell cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 1997;19:74-82.
24. Nielsen SE, Dragsted LO. Column-switching high-performance liquid chromatographic assay for determination of apigenin and acacetin in human urine with ultraviolet absorbance detection. J Chromatogr 1998;713:379-386.
25. Haapajarvi T, Kivinen L, Pitanen K, Laiho M. Cell cycle dependent effects of U.V.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncology 1995;11:150-159.
26. Mitchell CE, Belinsky SA, Lechner JF. Detection and quantitation of mutant K-RAS codon 12 restriction fragments by capillary electrophoresis. Anal Biochem 1995;224: 148-153.
27. Nagasawa H, Li CY, Maki CG, Imrich AC, Little JB. Relationship between radiation-induced G1 phase arrest and p53-function in human tumor cells. Cancer Res 1995;55: 1842-1846.
28. Lorentz O, Cadoret A, Duluc I, et al. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras. Oncogene 1999;18:87-92.
29. Gartel AL, Serfas MS, Gartel M, et al. P21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exp Cell Res 1996;227:171-181.
30. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-1112.
31. Higuchi CM, Wang W. Comodulation of cellular polyamines and proliferation: Biomarker application to colorectal mucosa. J Cell Biochem 1995;57:256-261.
32. Nojima H. Cell cycle checkpoints, chromosome stability and the progression of cancer. Hum Cell 1997;10:221-230.
33. Deschner EE, Ruperto J, Wong G, Newmark HL. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991;12:1193-1196.
34. Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis 1995;16:2833-2840.
35. Kaur G, Stetler-Stevenson M, Sehers S, et al. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J Natl Cancer Inst 1992;84: 1736-1740.
36. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD. Flavonoids activate wild-type p53. Oncogene 1996;13: 1605-1614.
37. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-532.
38. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
39. Kinzler KW, Vogelstein B Gatekeepers and caretakers. Nature 1997;386:761-763.
40. Shackney SE, Shankey TV. Common patterns of genetic evolution in human solid tumors. Cytometry 1997;29:1-27.
41. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Molecular biology of colorectal cancer. Curr Probl Cancer 1997;21:233-300.
42. Tian JO, Ouaroni A. Dissociation between growth arrest and differentiation in Caco-2 subclone expression high levels of sucrase. Am J Physiol 1999;276:G1094-G1104.
43. Sinicrope FA, Roddey G, Lemoine M, et al. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers. Clin Cancer Res 1998;4: 1251-1261.